$15M funding aims to advance stem cell therapies for petsJanuary 8, 2024The financing will go toward achieving the conditional U.S. Food and Drug Administration (FDA) approval of Gallant Therapeutic’s candidate for feline chronic gingivostomatitis
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More